This Week's Poll

At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you

Supported by Medilink UK

Collaboration to reduce costs - Sue Wilde of - myM-link - 11:29:22am Jun-30th

I've been noticing that in these tough economic times many more companies are working together to get new products to market. myM-link, the membership arm of MedilinkWM, has had a hand in directly assisting a number of companies to increase their bottom line, most recently putting Kimal and Openhouse together for the nationally-recognised launch of the UK’s first mobile pack for people reliant on infusion for nutrition or pain relief. Is this because partnership can be a way to share the cost, shorten development times and reduce risk?

Agree/Disagree + add comment
 
 
t